IFN-alpha skews monocyte differentiation into Toll-like receptor 7-expressing dendritic cells with potent functional activities.
about
Plasmacytoid dendritic cells: linking innate and adaptive immunityThe amino-terminal domain of bovine viral diarrhea virus Npro protein is necessary for alpha/beta interferon antagonism.Plasmacytoid dendritic cells and type I IFN: 50 years of convergent historyGene network reconstruction reveals cell cycle and antiviral genes as major drivers of cervical cancerThe detrimental effects of IFN-α on vasculogenesis in lupus are mediated by repression of IL-1 pathways: potential role in atherogenesis and renal vascular rarefaction.Interferon alpha in systemic lupus erythematosusTherapeutic strategies for SLE involving cytokines: mechanism-oriented therapies especially IFN-gamma targeting gene therapy.Interferon-α accelerates murine systemic lupus erythematosus in a T cell-dependent manner.Dendritic cell subsets in health and disease.Topical imiquimod has therapeutic and immunomodulatory effects against intracranial tumorsRoles of TLR7 in activation of NF-κB signaling of keratinocytes by imiquimod.Concomitant detection of IFNα signature and activated monocyte/dendritic cell precursors in the peripheral blood of IFNα-treated subjects at early times after repeated local cytokine treatments.Regulation of development of CD56 bright CD11c + NK-like cells with helper function by IL-18.Immune-mediated changes in actinic keratosis following topical treatment with imiquimod 5% cream.Roles of pro- and anti-inflammatory cytokines in the pathogenesis of SLEThe role of type I interferons in non-viral infections.Interferon alpha and T-cell responses in chronic myeloid leukemia.Interferon-alpha promotes abnormal vasculogenesis in lupus: a potential pathway for premature atherosclerosis.Characterization of type I interferon pathway during hepatic differentiation of human pluripotent stem cells and hepatitis C virus infection.Current state and perspectives of dendritic cell vaccination in cancer immunotherapy.Epidemiologic, experimental, and clinical links between respiratory syncytial virus infection and asthma.TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity.Current approaches in dendritic cell generation and future implications for cancer immunotherapy.The role of type I interferon production by dendritic cells in host defense.Regulation of interferon and Toll-like receptor signaling during macrophage activation by opposing feedforward and feedback inhibition mechanisms.Differential expression of constitutive and inducible proteasome subunits in human monocyte-derived DC differentiated in the presence of IFN-alpha or IL-4.Physiological role of plasmacytoid dendritic cells and their potential use in cancer immunity.Dendritic cells in the pathogenesis of sarcoidosis.The role IL-1 in tumor-mediated angiogenesis.Interferon-α in the generation of monocyte-derived dendritic cells: recent advances and implications for dermatology.Type I interferons as regulators of human antigen presenting cell functions.Oncolytic Newcastle Disease Virus as Cutting Edge between Tumor and HostType I IFN-mediated synergistic activation of mouse and human DC subsets by TLR agonists.Processing of human toll-like receptor 7 by furin-like proprotein convertases is required for its accumulation and activity in endosomes.Effective induction of melanoma-antigen-specific CD8+ T cells via Vγ9γδT cell expansion by CD56(high+) Interferon-α-induced dendritic cells.Interferon-alpha and viral triggers promote functional maturation of human monocyte-derived dendritic cells.Monocyte derived dendritic cells generated by IFN-alpha acquire mature dendritic and natural killer cell properties as shown by gene expression analysis.Viral danger signals control CD1d de novo synthesis and NKT cell activation.Interferon-alpha2a is sufficient for promoting dendritic cell immunogenicity.Dendritic cell therapy with interferon-alpha synergistically suppresses outgrowth of established tumors in a murine colorectal cancer model.
P2860
Q24558695-231C8355-D0F2-4E05-8A18-624EEA8CE353Q27472819-CB53B3B5-5C96-41A2-BC39-E1A7F1715E5EQ27485637-E41145FD-E028-49D5-9D42-30451B542060Q28119171-D184FEEB-2203-4DC6-B66B-881FFB058991Q30497355-45275DEA-0712-45FD-87BC-4D719272908CQ33961179-30E9999D-015A-4E59-9185-AFBB76BC3581Q34106220-1F54AEF8-6D0A-4C09-80B7-978580CEE0F1Q34462033-CE14C409-78F7-47D6-8557-3C43CF9A5E80Q34582889-B7754B04-4C40-4256-AB12-55F6E4C6D6C3Q34777706-9289FA37-393E-486A-9456-574AFF6F414CQ35023079-F177D4EF-45DE-4593-AFCC-3447029E3533Q35047686-B0F8B41F-A940-4A85-B892-41AC6C4216A0Q35077632-FC0A4169-42DE-4F71-9012-34EF0DF18262Q35632513-16344E93-5336-43F8-9C96-26EE520FAC68Q35829864-0C3C87C5-166A-4E0D-BF7F-DCEA8767BCF7Q35951793-3E38A14A-DA92-4F0C-9472-C042444EAF48Q35994924-45D32BDD-2816-47CD-AF84-F5D1ADBCDE97Q36059617-46C277E3-5DD1-42AD-A311-48C7AE3E4767Q36145616-FFA613A0-7F53-4A42-99FD-CD3A901F90CEQ36448084-EBA2DA83-9E75-4B11-A527-17188D7ABA69Q36803900-288A023D-DC82-49CF-A8CE-034E72348D94Q36811126-A0C98E79-C2AD-46C5-A5E4-2FBDC3FC63ACQ36822028-3718FE4D-E11A-491D-9000-D7C386EE7DBCQ36838232-E51A9ED3-6243-4A65-95D0-9A8791722ECCQ37071983-5EB56C03-A308-44C2-B6BD-F1AB608F4DC7Q37354906-7047CA8C-BD03-40CC-811A-B6D969EFF45CQ37384753-BAE13B8C-6013-448E-9691-42CA1AC5F8DCQ37446493-1E0AABDB-0387-4475-9E13-6D9F7D24109DQ37683553-E9116EF2-A108-4AA8-A50C-D3696C1364E0Q37853631-220C7493-F30F-4AA4-AF5C-2DB83D6C0440Q38215320-42C8110D-75EC-489B-8068-DAD810A8DB95Q38369289-D6B33C9E-123C-4E49-9A7F-E3148A61D175Q38976179-C3FF3427-C459-4F61-ADA7-F84A33C27F15Q39076945-41C2EA8E-8ABD-486A-833C-0E9F5B61FAE3Q39104547-E97F9312-0086-496D-A1F6-7A1AC45021E4Q39297697-65D5C812-BD59-45DA-BF5C-9125D219E69CQ39755645-5B9C5E7B-D232-4902-9AF5-62EFCEA37C71Q40015983-72456965-5639-4533-AA30-553219AD3712Q40349921-F923DF00-CFFB-4CD3-9C8F-D495E1DF9D4DQ40383917-69C8EC74-BD45-49A4-BF74-A664A4A70356
P2860
IFN-alpha skews monocyte differentiation into Toll-like receptor 7-expressing dendritic cells with potent functional activities.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
IFN-alpha skews monocyte diffe ...... potent functional activities.
@en
type
label
IFN-alpha skews monocyte diffe ...... potent functional activities.
@en
prefLabel
IFN-alpha skews monocyte diffe ...... potent functional activities.
@en
P2093
P1476
IFN-alpha skews monocyte diffe ...... potent functional activities.
@en
P2093
Alexandra Vialle-Castellano
Béatrice Gaugler
Daniel Isnardon
Daniel Olive
Jacques A Nunes
Mohamad Mohty
P304
P356
10.4049/JIMMUNOL.171.7.3385
P407
P577
2003-10-01T00:00:00Z